Related Experiment Video
Updated: Jul 12, 2026

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver
Michihiro Matsumoto1, Alessandro Pocai, Luciano Rossetti
1Naomi Berrie Diabetes Center, Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
Abstract:
The hallmark of type 2 diabetes is excessive hepatic glucose production. Several transcription factors and coactivators regulate this process in cultured cells. But gene ablation experiments have yielded few clues as to the physiologic mediators of this process in vivo. We show that inactivation of the gene encoding forkhead protein Foxo1 in mouse liver results in 40% reduction of glucose levels at birth and 30% reduction in adult mice after a 48 hr fast. Gene expression and glucose clamp studies demonstrate that Foxo1 ablation impairs fasting- and cAMP-induced glycogenolysis and gluconeogenesis. Pgc1alpha is unable to induce gluconeogenesis in Foxo1-deficient hepatocytes, while the cAMP response is significantly blunted. Conversely, Foxo1 deletion in liver curtails excessive glucose production caused by generalized ablation of insulin receptors and prevents neonatal diabetes and hepatosteatosis in insulin receptor knockout mice. The data provide a unifying mechanism for regulation of hepatic glucose production by cAMP and insulin.
Insights
Forkhead protein Foxo1 inactivation in mouse liver significantly reduces glucose levels by impairing key production pathways. This finding offers a unifying mechanism for hepatic glucose regulation by insulin and cAMP.
Area of Science:
- Metabolism
- Endocrinology
- Molecular Biology
Background:
- Type 2 diabetes is characterized by excessive hepatic glucose production, a process regulated by various factors in cultured cells.
- In vivo identification of key mediators of hepatic glucose production has been challenging.
Purpose of the Study:
- To investigate the role of forkhead protein Foxo1 in regulating hepatic glucose production in vivo.
- To elucidate the mechanism by which Foxo1 influences gluconeogenesis and glycogenolysis.
Main Methods:
- Gene ablation of Foxo1 in mouse liver.
- Gene expression analysis.
- Glucose clamp studies.
- Analysis of insulin receptor knockout mice.
Main Results:
- Foxo1 inactivation in mouse liver reduced glucose levels at birth and after fasting.
- Foxo1 ablation impaired fasting- and cAMP-induced glycogenolysis and gluconeogenesis.
- Foxo1 deletion prevented neonatal diabetes and hepatosteatosis in insulin receptor knockout mice.
Conclusions:
- Foxo1 is a critical regulator of hepatic glucose production in vivo.
- Foxo1 mediates the effects of cAMP and insulin on glucose metabolism.
- Targeting Foxo1 may offer a therapeutic strategy for type 2 diabetes.
Related Concept Videos
Cell Specific Gene Expression
Type II Diabetes II: Pathophysiology
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

